Polen Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$117M |
| 2 |
Align Technology
ALGN
|
+$98.3M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$71.5M |
| 4 |
Visa
V
|
+$58.1M |
| 5 |
Nike
NKE
|
+$54.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$135M |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$4.81M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 28.52% |
| 2 | Technology | 26.77% |
| 3 | Communication Services | 14.75% |
| 4 | Healthcare | 11.66% |
| 5 | Financials | 9.61% |
Similar funds
Polen Capital Management's Q1 2016 Portfolio in Review
As of Q1 2016, Polen Capital Management held 27 positions worth $7.28B, up 13% from $6.47B the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Polen Capital Management deployed $773M of net new capital in Q1 2016, opening 1 new position and adding to 24 existing holdings. Its largest new stake was Align Technology: 1,500,605 shares worth $109M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 29% of assets, up from 28% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Abbott, an estimated $135M trimmed.
- Polen Capital Management's largest Q1 2016 buy was Align Technology: 1,500,605 shares worth $109M.
- Polen Capital Management added most to Celgene Corp in Q1 2016, an estimated $117M increase.
- Polen Capital Management's biggest Q1 2016 reduction was Abbott, cutting an estimated $135M.
- Polen Capital Management's ten largest holdings make up 58% of its $7.28B portfolio in Q1 2016.
- Polen Capital Management opened 1 new position and closed 0 in Q1 2016.
- Polen Capital Management's portfolio value rose 13% quarter-over-quarter to $7.28B.
Based on Polen Capital Management's 13F filing for Q1 2016, filed 16 May 2016.